“…Although C10 did not reduce SVCV replication in the early stage of viral infection, it significantly reduced SVCV replication during viral biosynthesis, as observed in time-of-addition and time-of-removal analyses. Compared with other 7-hydroxy-imidazole coumarin medicines, such as 7-(3-benzimidazole propoxy) coumarin (B4) ( Qiu et al, 2020 ), 7-(4-(4-methyl-imidazole))-coumarin (C2) ( Liu et al, 2019a ), 7-(4-benzimidazole-butoxy)-coumarin (BBC) ( Liu et al, 2018 ; Shen et al, 2018 ), 4-phenyl-2-thioxo-1,2,3,4-tetrahydro-5H-chromeno[4,3-d] pyrimidin-5-one (S5) ( Song et al, 2020 ) and 7-(6-(2-methyl-imidazole))-coumarin (D5) ( Liu et al, 2019b ), C10 demonstrated lower acute toxicity in zebrafish, and could therefore be used as a viable agent for preventing and controlling SVCV infection.…”